These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery. Bjellerup P, Theodorsson E, Kogner P. Eur J Cancer; 1995; 31A(4):481-5. PubMed ID: 7576950 [Abstract] [Full Text] [Related]
13. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. Orlando C, Raggi CC, Bagnoni L, Sestini R, Briganti V, La Cava G, Bernini G, Tonini GP, Pazzagli M, Serio M, Maggi M. Med Pediatr Oncol; 2001 Jan; 36(1):224-6. PubMed ID: 11464890 [Abstract] [Full Text] [Related]
18. Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma. Combaret V, Gross N, Lasset C, Frappaz D, Beretta-Brognara C, Philip T, Beck D, Favrot MC. Eur J Cancer; 1997 Oct; 33(12):2101-5. PubMed ID: 9516862 [Abstract] [Full Text] [Related]
19. Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN. Koppen A, Ait-Aissa R, Koster J, Øra I, Bras J, van Sluis PG, Caron H, Versteeg R, Valentijn LJ. Int J Cancer; 2008 Apr 01; 122(7):1455-64. PubMed ID: 18059033 [Abstract] [Full Text] [Related]
20. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. Manil L, Edeline V, Lumbroso J, Lequen H, Zucker JM. J Nucl Med; 1996 Jun 01; 37(6):893-6. PubMed ID: 8683306 [Abstract] [Full Text] [Related] Page: [Next] [New Search]